About Novalead Pharma Private Limited
Data last updated:
Novalead Pharma Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 31 October 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U73100PN2007PTC130929. Its GSTIN is 27AACCN6310K1ZH (Maharashtra).
The company has an authorised share capital of ₹3.74 Cr and a paid-up capital of ₹1.81 Lakh. It is led by directors including Sudhir Kulkarni Appaji and Atul Sharad Aslekar.
Its last annual general meeting (AGM) was held on 24 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 05 Third Floor Ram Indu Park, Pune, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹16.39 Lakh, a decline of 97% compared to the previous year. For the same year it recorded a net loss of ₹3.53 Cr and EBITDA of -₹3.13 Cr. Revenue has declined at a compounded annual rate (CAGR) of 49% over three years and 38% over five years.
The company is associated with 3 brands: WoundlyClinical, VLife Sciences Technologies and NovaLead Pharma. As per MCA filings, the company has satisfied charges of ₹3.34 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company. The company has 13 deals on record (6 secondary share transfers, 5 funding rounds, 1 rights issue), with disclosed funding of ₹43.9 Cr; the latest was in March 2021. Its 10 peer companies in the Healthcare industry (Contract Research, Healthcare Technology) are compared by revenue, 5 larger and 5 smaller; the largest is Chandvel Technologies Private Limited with revenue of ₹16.5 Lakh.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website novaleadpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressPlot No – 05 Third Floor Ram Indu Park Survey No – 131/1B/2/11 Baner Taluka Have, Li, Pune, Maharashtra, India – 411045
- IndustryPharma, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Novalead Pharma Private Limited
Novalead Pharma operates multiple associated brands including WoundlyClinical, VLife Sciences Technologies, and NovaLead Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers an app for monitoring and managing wound healing progression. | woundlyclinical.com | |
| Solutions for computer-aided drug design are provided to researchers. | vlifesciences.com | |
| Drug repurposing and discovery are enabled by a proprietary platform. | novaleadpharma.com |
Business Activity of Novalead Pharma Private Limited
The main business activities of Novalead Pharma are professional, scientific and technical and information and communication. In detail, this covers scientific research and development and computer programming, consultancy and related activities. 2 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
| J | Information and communication | J6 | Computer programming, consultancy and related activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Novalead Pharma Private Limited FY 2024 filings available
Novalead Pharma Private Limited reported revenue of ₹16.39 Lakh (down 97% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Novalead Pharma Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 38% over five years, including a 97% fall in the latest year. EBITDA fell 248% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Novalead Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹3.13 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹3.53 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Novalead Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | •••• | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Novalead Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Novalead Pharma Private Limited
Novalead Pharma has 6 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sankara Narayanan Sankarasubramanian | Nominee Director | 24 Nov 2022 | 3 Years 10 Months | Current |
| Sudhir Kulkarni Appaji | Director | 17 Aug 2009 | 17 Years 2 Months | Current |
| Vandan Girdharlal Agrawal | Nominee Director | 24 Nov 2022 | 3 Years 10 Months | Current |
| Atul Sharad Aslekar | Director | 31 Oct 2007 | 18 Years 11 Months | Current |
| Supreet Deshpande Kiran Also directs: Anaahat Art Foundation | Director | 31 Oct 2007 | 18 Years 11 Months | Current |
| Girish Vithalrao Lakhe Also directs: Fiscus Capital Advisors Limited Liability Partnership | Director | 17 Aug 2009 | 17 Years 2 Months | Current |
Peer Comparison of Novalead Pharma Private Limited
Novalead Pharma Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Contract Research, Healthcare Technology). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Chandvel Technologies Private Limited | ₹16.5 Lakh (FY 2023) | •••• | •••• | 2080.0% | •••• | Chennai, Tamil Nadu, India |
| GSG Pharmaceuticals Private Limited | ₹16.47 Lakh (FY 2025) | •••• | •••• | 0.0% | •••• | Mumbai, Maharashtra, India |
| Oxygen Therapeutics India Private Limited | ₹16.46 Lakh (FY 2025) | •••• | •••• | -28.0% | •••• | Delhi, India |
| Parthys Reverse Informatics Analytic Solutions Private Limited | ₹16.44 Lakh (FY 2024) | •••• | •••• | -70.0% | •••• | Chennai, Tamil Nadu, India |
| Epmware India Private Limited | ₹16.43 Lakh (FY 2025) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Novalead Pharma Private Limited this company | ₹16.39 Lakh (FY 2024) | •••• | •••• | -97.0% | •••• | Pune, Maharashtra, India |
| Trachealth Technologies Private Limited | ₹16.39 Lakh (FY 2025) | •••• | •••• | -49.0% | •••• | Mangalore, Karnataka, India |
| Dr Hatankar's Scientific Ayurveda Private Limited | ₹16.22 Lakh (FY 2025) | •••• | •••• | 43.0% | •••• | Pimpri, Maharashtra, India |
| SNDJ Advisory Private Limited | ₹16.2 Lakh (FY 2025) | •••• | •••• | •••• | Ahmedabad, Gujarat, India | |
| Lara Orthopaedic Solution Private Limited | ₹16.09 Lakh (FY 2023) | •••• | •••• | -67.0% | •••• | Chennai, Tamil Nadu, India |
| Previu Health Private Limited | ₹16.05 Lakh (FY 2025) | •••• | •••• | •••• | Ernakulam, Kerala, India |
Peers are the five companies nearest above and the five nearest below Novalead Pharma by revenue in the Healthcare industry (Contract Research, Healthcare Technology), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Novalead Pharma Private Limited
Novalead Pharma Private Limited is audited by G D APTE & CO. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| G D APTE & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Novalead Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Novalead Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Jan 2011 | Biotechnology Industry Research Assistance Council | ₹3.34 Cr | Satisfied |
Total charge records: 1 View all charges
Deals & Funding of Novalead Pharma Private Limited
Novalead Pharma Private Limited has 13 deals on record (6 secondary share transfers, 5 funding rounds, 1 rights issue), with disclosed funding of ₹43.9 Cr; the latest was in March 2021.
Deals on record (5 of 13)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: an individual |
| Mar 2021 | Funding round | ₹40 Lakh | Investors: an individual |
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Dec 2008 | Secondary share transfer | Undisclosed | Buyer: Kotak Private Equity, 3 individuals Seller: Vlife Sciences Technologies Private Limited |
| Jan 2008 | Acquisition | Undisclosed | Buyer: Vlife Sciences Technologies Private Limited Seller: 2 individuals |
Full deal history
All 13 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Novalead Pharma Private Limited
Novalead Pharma Private Limited has 2 court cases on record: 2 filed by Novalead Pharma. All cases are disposed. Status as checked on 30 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (CSP) | Filed by the company | Disposed |
| Bombay High Court | Court case (CSD) | Filed by the company | Disposed |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Novalead Pharma Private Limited
Employment history and EPFO contributions of people linked to Novalead Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Novalead Pharma Private Limited
Novalead Pharma Private Limited has 16 board changes on record since 2007: 6 appointments and 10 cessations. The latest: Vandan Girdharlal Agrawal ceased to be Additional Director on 29 Nov 2022.
10 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Novalead Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Novalead Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Novalead Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Novalead Pharma Private Limited
Novalead Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCN6310K1ZH | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Novalead Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about Novalead Pharma Private Limited
Frequently Asked Questions about Novalead Pharma Private Limited
Novalead Pharma is an active private limited company based in Pune, Maharashtra, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 31 October 2007 (19+ years old) and is registered under CIN U73100PN2007PTC130929.
Novalead Pharma reported revenue of ₹16.39 Lakh for FY 2024 (down 97% YoY).
Novalead Pharma has 6 current directors:
- Sankara Narayanan Sankarasubramanian - Nominee Director
- Sudhir Kulkarni Appaji - Director
- Vandan Girdharlal Agrawal - Nominee Director
- Atul Sharad Aslekar - Director
- Supreet Deshpande Kiran - Director
- Girish Vithalrao Lakhe - Director
Novalead Pharma reported a net loss of ₹3.53 Cr and EBITDA of -₹3.13 Cr for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Novalead Pharma is -49% over three years and -38% over five years. In the latest year (FY 2024) revenue fell 97%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Novalead Pharma is 27AACCN6310K1ZH, registered in Maharashtra.
The CIN (Corporate Identification Number) of Novalead Pharma is U73100PN2007PTC130929. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Novalead Pharma has 2 court cases on record: 2 filed by the company.
Novalead Pharma was incorporated on 31 October 2007, making it 19+ years old. It is registered with the Registrar of Companies, Pune.
Novalead Pharma has 13 deals on record (6 secondary share transfers, 5 funding rounds, 1 rights issue), with disclosed funding of ₹43.9 Cr; the latest was in March 2021.
The peers of Novalead Pharma by revenue are Chandvel Technologies Private Limited, GSG Pharmaceuticals Private Limited, Oxygen Therapeutics India Private Limited, Parthys Reverse Informatics Analytic Solutions Private Limited, Epmware India Private Limited and 5 more, all in the Healthcare industry (Contract Research, Healthcare Technology).